HER-2 Positive Advanced Solid Tumors
1 clinical trials · Condition
◉ Watch HER-2 Positive Advanced Solid Tumors
| Record | Firm | Date |
|---|---|---|
| A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors (NCT05957536) | D3 Bio (Wuxi) Co., Ltd | 2023-09-19 |
Track HER-2 Positive Advanced Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.